F de Vathaire

Author PubWeight™ 36.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Second primary malignancies in thyroid cancer patients. Br J Cancer 2003 2.10
2 Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med 1998 1.94
3 Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997 1.84
4 Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991 1.77
5 Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer 1990 1.55
6 Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients. Eur J Nucl Med Mol Imaging 2004 1.39
7 Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 1998 1.32
8 Leukaemia mortality in French communes (administrative units) with a large and rapid population increase. Br J Cancer 1994 1.29
9 Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003 1.29
10 Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer 2004 1.29
11 Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 1998 1.17
12 Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996 1.12
13 Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000 1.09
14 Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study. Int J Cancer 1990 1.06
15 Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys 1997 1.02
16 Undifferentiated carcinoma of nasopharyngeal type of tonsil. Arch Otolaryngol Head Neck Surg 1989 0.93
17 Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric 2002 0.92
18 Cancer registry of French Polynesia: results for the 1990-1995 period among native and immigrant population. Eur J Epidemiol 2000 0.88
19 Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 2003 0.86
20 Irradiation and second cancers. The thyroid as a case in point. C R Acad Sci III 1999 0.86
21 Cancer incidence in French Polynesia 1985-95. Trop Med Int Health 2000 0.83
22 Estimation of the radiation dose from radiotherapy for skin haemangiomas in childhood: the ICTA software for epidemiology. Phys Med Biol 2000 0.81
23 Individual radiation therapy patient whole-body phantoms for peripheral dose evaluations: method and specific software. Phys Med Biol 2009 0.80
24 Irradiated neuroblastoma in childhood as potential risk factor for subsequent thyroid tumour. Lancet 1988 0.80
25 OECI Workshop on late side-effects of cancer treatments. Eur J Cancer 2008 0.78
26 Incidence of haematological malignancies in French Polynesia between 1990 and 1995. Leuk Res 1999 0.78
27 Thyroid volume measurement in external beam radiotherapy patients using CT imaging: correlation with clinical and anthropometric characteristics. Phys Med Biol 2010 0.78
28 Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double-blind, placebo-controlled, clinical study. Curr Med Res Opin 2010 0.78
29 Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease. Cancer 1991 0.78
30 Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood. Radiother Oncol 1998 0.78
31 [Female genital and breast cancers in France: geographic distribution and estimation of incidence]. Bull Cancer 1997 0.76
32 Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis. Prog Clin Biol Res 1994 0.76
33 [Thyroid cancer following exposure to ionising radiation]. Cancer Radiother 2011 0.76
34 [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]. Bull Cancer 1997 0.75
35 Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow. Br J Cancer 1989 0.75
36 Radiosensitivity of mouse lip mucosa: influence of anesthesia, carbogen, and a new high O2 carrying perfluorochemical emulsion. Radiat Res 1989 0.75
37 O.E.S.O.* collaborative studies Launching of an international study on esophagitis, Barrett's esophagus and esophageal dysplasia. Attempt to a new pathological prognostic index for cancer of the esophagus. Dis Esophagus 1988 0.75
38 Risk of melanoma following adulthood cancer: a case-control study. Eur J Cancer 2005 0.75
39 [Male fertility after chemotherapy during childhood]. Ann Endocrinol (Paris) 1995 0.75
40 [Study of the distribution of HLA antigens within a population and a comparison between 2 populations]. Rev Epidemiol Sante Publique 1986 0.75
41 Thyroglobulin level helps to predict recurrence after lobo-isthmusectomy in patients with differentiated thyroid carcinoma. Lancet 1988 0.75
42 How to collect pertinent data for the assessment of the medical consequences of an irradiation? C R Acad Sci III 1999 0.75
43 Differentiated thyroid carcinoma incidence around the French nuclear power plant in Chooz. Lancet 1993 0.75
44 Cancer mortality during the 1968-1994 period in a mining area in France. Eur J Cancer Prev 2005 0.75
45 Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma. J Clin Oncol 1993 0.75